Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives
Current Opinion in Oncology, 10/14/09
Falini B et al. – Nucleophosmin (NPM1) gene mutations, which cause aberrant cytoplasmic expression of nucleophosmin (NPMc+), are the most frequent genetic alteration in acute myeloid leukemia (AML), being found in about 30% cases. The present review summarizes recent advances in the biology, diagnosis, prognosis and therapy of NPM1–mutated AML. AML with mutated NPM1 is a leukemia entity with distinct molecular, pathological, and prognostic features.
Related Articles
Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome
Cancer, 10/29/09
Relevance Score: 90%
Daunorubicin Versus Mitoxantrone Versus Idarubicin as Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
Journal of Clinical Oncology, 10/23/09
Relevance Score: 90%
FLT3 inhibition as a targeted therapy for acute myeloid leukemia
Current Opinion in Oncology, 10/14/09
Relevance Score: 90%
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome
Blood, 10/02/09
Relevance Score: 90%
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations
Blood, 10/13/09
Relevance Score: 89%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Endocellular polyamine availability modulates epithelial-to-mesenchymal transition and unfolded protein response in MDCK cells
Laboratory Investigation, 03/19/10
Functional significance of the two ACOX1 isoforms and their crosstalks with PPAR[alpha] and RXR[alpha]
Laboratory Investigation, 03/19/10
Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing
Laboratory Investigation, 03/19/10
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode
Breast Cancer Research and Treatment, 03/19/10
Imprint cytology in tumor tissue bank quality control: an efficient method to evaluate tumor necrosis and to detect samples without tumor cells
Virchows Archiv, 03/19/10
Difficulties in Diagnosing Congenital Thrombotic Thrombocytopenic Purpura
Journal of Pediatric Hematology/Oncology, 03/19/10
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Final analysis of the UKLG LY02 trial comparing 6–8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL
British Journal of Haematology, 03/19/10
Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders
British Journal of Haematology, 03/19/10
High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
British Journal of Haematology, 03/19/10
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


